| Gene symbol | IFNA2 | Synonyms | IFN-alpha-2, IFN-alphaA, IFNA, IFNA2B, leIF A | Type of gene | protein-coding |
| Chromosome | 9 | Map location | 9p21.3 | dbXrefs | |
| Description | interferon alpha 2 | ||||
| GTO ID | GTC2067 |
| Trial ID | NCT03866109 |
| Disease | Glioblastoma Multiforme |
| Altered gene | IFNA2 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Temferon |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Phase I/IIa Dose Escalation Study Evaluating the Safety and Efficacy of Autologous CD34+-Enriched HSPCs Genetically Modified With Human Interferon-α2 in Patients With Glioblastoma Multiforme and Unmethylated MGMT Gene Promoter |
| Year | 2019 |
| Country | Italy |
| Company sponsor | Genenta Science |
| Other ID(s) | TEM-GBM_001|2018-001404-11 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||